HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹1,590 Cr | ₹1,621 Cr | ₹1,446 Cr | ₹1,305 Cr | ₹1,091 Cr |
What is the latest Total Non-Current Assets ratio of HIKAL ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹1,590 Cr |
| Mar2024 | ₹1,621 Cr |
| Mar2023 | ₹1,446 Cr |
| Mar2022 | ₹1,305 Cr |
| Mar2021 | ₹1,091 Cr |
How is Total Non-Current Assets of HIKAL Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,590 Cr | -1.93 | |
| Mar2024 | ₹1,621 Cr | 12.05 | |
| Mar2023 | ₹1,446 Cr | 10.86 | |
| Mar2022 | ₹1,305 Cr | 19.64 | |
| Mar2021 | ₹1,091 Cr | - | |
Compare Total Non-Current Assets of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,993.7 Cr | 1.2% | -6.6% | -34.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,791.0 Cr | 1.2% | 4.2% | -10.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,885.0 Cr | -0.5% | 8.9% | 10.8% | Stock Analytics | |
| CIPLA | ₹127,930.0 Cr | 0.4% | 3.7% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,108.0 Cr | -0% | -2.1% | 6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,164.0 Cr | 2.2% | -1.8% | -4.4% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 1.2% |
-6.6% |
-34.1% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses